JPWO2023207283A5 - - Google Patents
Info
- Publication number
- JPWO2023207283A5 JPWO2023207283A5 JP2024563976A JP2024563976A JPWO2023207283A5 JP WO2023207283 A5 JPWO2023207283 A5 JP WO2023207283A5 JP 2024563976 A JP2024563976 A JP 2024563976A JP 2024563976 A JP2024563976 A JP 2024563976A JP WO2023207283 A5 JPWO2023207283 A5 JP WO2023207283A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- compound
- independently selected
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/089986 | 2022-04-28 | ||
| CN2022089986 | 2022-04-28 | ||
| PCT/CN2023/077272 WO2023207283A1 (en) | 2022-04-28 | 2023-02-20 | Compounds as parp1 inhibitiors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025517106A JP2025517106A (ja) | 2025-06-03 |
| JPWO2023207283A5 true JPWO2023207283A5 (https=) | 2026-02-27 |
| JP2025517106A5 JP2025517106A5 (https=) | 2026-02-27 |
Family
ID=88517229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024563976A Pending JP2025517106A (ja) | 2022-04-28 | 2023-02-20 | Ｐａｒｐ１阻害剤としての化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250289814A1 (https=) |
| EP (1) | EP4514795A4 (https=) |
| JP (1) | JP2025517106A (https=) |
| KR (1) | KR20250033148A (https=) |
| CN (1) | CN119487027A (https=) |
| WO (1) | WO2023207283A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023209820B2 (en) | 2022-01-21 | 2024-10-10 | Xinthera, Inc. | Parp1 inhibitors and uses thereof |
| KR20240161147A (ko) | 2022-03-14 | 2024-11-12 | 슬랩 파마슈티컬스 엘엘씨 | 다중 사이클릭 화합물 |
| FI4497438T3 (fi) | 2022-04-28 | 2025-10-20 | Xinthera Inc | Trisyklisiä parp1:n estäjiä ja niiden käyttötapoja |
| TW202416977A (zh) * | 2022-09-30 | 2024-05-01 | 大陸商中國醫藥研究開發中心有限公司 | 含氮雜環類化合物及其醫藥用途 |
| US20250129051A1 (en) * | 2023-10-23 | 2025-04-24 | Gilead Sciences, Inc. | Parp1 inhibitors and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9903758A3 (en) * | 1996-05-29 | 2000-07-28 | Warner Lambert Co | Benzoxazinone dopamine d4 receptor antagonists and pharmaceutical compositions containing the same |
| GB0227240D0 (en) * | 2002-11-21 | 2002-12-31 | Glaxo Group Ltd | Compounds |
| RU2007101544A (ru) * | 2004-06-17 | 2008-08-10 | Уайт (Us) | Антагонисты рецепторов высвобождающего гонадотропин гормона |
| US8404713B2 (en) * | 2007-10-26 | 2013-03-26 | Janssen Pharmaceutica Nv | Quinolinone derivatives as PARP inhibitors |
| AR070221A1 (es) * | 2008-01-23 | 2010-03-25 | Astrazeneca Ab | Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas. |
| WO2010111626A2 (en) * | 2009-03-27 | 2010-09-30 | Takeda Pharmaceutical Company Limited | Poly (adp-ribose) polymerase (parp) inhibitors |
| MX2022000711A (es) * | 2019-07-19 | 2022-02-23 | Astrazeneca Ab | Inhibidores de parp1. |
| TW202309025A (zh) * | 2021-04-19 | 2023-03-01 | 美商辛瑟拉股份有限公司 | Parp1抑制劑及其用途 |
| WO2022228387A1 (en) * | 2021-04-26 | 2022-11-03 | Fochon Biosciences, Ltd. | Compounds as parp inhibitors |
| US20230159525A1 (en) * | 2021-10-01 | 2023-05-25 | Xinthera, Inc. | Azetidine and pyrrolidine parp1 inhibitors and uses thereof |
| TW202416977A (zh) * | 2022-09-30 | 2024-05-01 | 大陸商中國醫藥研究開發中心有限公司 | 含氮雜環類化合物及其醫藥用途 |
-
2023
- 2023-02-20 EP EP23794719.7A patent/EP4514795A4/en active Pending
- 2023-02-20 JP JP2024563976A patent/JP2025517106A/ja active Pending
- 2023-02-20 KR KR1020247039613A patent/KR20250033148A/ko active Pending
- 2023-02-20 WO PCT/CN2023/077272 patent/WO2023207283A1/en not_active Ceased
- 2023-02-20 CN CN202380050136.0A patent/CN119487027A/zh active Pending
- 2023-02-20 US US18/861,016 patent/US20250289814A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2799437B1 (en) | Quinoline and cinnoline derivatives and use thereof | |
| TWI296524B (en) | Angiogenesis inhibitors | |
| CN104736155B (zh) | 双环化合物作为激酶的抑制剂 | |
| JPWO2021013735A5 (https=) | ||
| EP2253625A1 (en) | Pyridazinones, the preparation and the use thereof | |
| JP2011509301A5 (https=) | ||
| EP2990057B1 (en) | Pai-1 inhibitor for use in enhancing the antitumor effect of an antitumor agent in a patient | |
| EP3710456B1 (en) | Macrocyclic indole derivatives | |
| US10752612B2 (en) | PLK4 inhibitors | |
| JP2007508238A5 (https=) | ||
| EP4331614A1 (en) | Use of medicament in treatment of tumor disease | |
| KR102038401B1 (ko) | 키나아제 억제제의 제조 및 응용 | |
| JP2011509302A5 (https=) | ||
| CN104230952B (zh) | 含有嘧啶骨架的化合物及其制备方法和用途 | |
| KR20180118745A (ko) | 소라페닙 또는 레고라페닙과 트록사시타빈의 포스포라미데이트 전구약물의 병용 요법 | |
| US20210395242A1 (en) | Heterocyclic compounds as ahr modulators | |
| CN111763215A (zh) | 一种具有含氮杂环结构的化合物及其制备方法和用途 | |
| CN111217815B (zh) | 含有喋啶酮骨架的化合物及其制备方法和应用 | |
| JPWO2023207283A5 (https=) | ||
| JP2017137323A (ja) | 新規抗がん剤 | |
| JPH07252147A (ja) | クマリン誘導体を含有する薬剤 | |
| CN114790207A (zh) | 作为pi3k/mtor抑制剂的被取代的吡啶基取代的稠合喹啉化合物 | |
| WO2025087460A1 (zh) | 一种吡啶并吡唑衍生物药物组合物及其应用 | |
| JPWO2020045461A1 (ja) | ピラゾロ［３，４−ｄ］ピリミジン化合物を有効成分とする治療剤 | |
| CN112442014B (zh) | Pdgfr激酶抑制剂及其用途 |